Joshi, K;
Chain, BM;
Peggs, KS;
Quezada, SA;
(2017)
The "Achilles Heel" of Cancer and Its Implications for the Development of Novel Immunotherapeutic Strategies.
Cold Spring Harbor Perspectives in Medicine
10.1101/cshperspect.a027086.
(In press).
Preview |
Text
Chain_Med FINAL_withfigs.pdf - Accepted Version Download (1MB) | Preview |
Abstract
Over the last century, scientists have embraced the idea of mobilizing antitumor immune responses in patients with cancer. In the last decade, we have seen the rebirth of cancer immunotherapy and its validation in a series of high profile clinical trials following the discovery of several immune-regulatory receptors. Recent studies point toward the tumor mutational load and resulting neoantigen burden as being crucial to tumor cell recognition by the immune system, highlighting a potentially targetable Achilles heel in cancer. In this review, we explore the key mechanisms that underpin the recognition of cancerous cells by the immune system and discuss how we may advance immunotherapeutic strategies to target the cancer mutanome to stimulate tumor-specific immune responses, ultimately, to improve the clinical outcome for patients with cancer.
Archive Staff Only
 |
View Item |
